Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
This report contains market size and forecasts of Tafenoquine in global, including the following market information:
Global Tafenoquine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tafenoquine Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Tafenoquine companies in 2021 (%)
The global Tafenoquine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tafenoquine include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tafenoquine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tafenoquine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tafenoquine Market Segment Percentages, by Type, 2021 (%)
Powder
Pills
Global Tafenoquine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tafenoquine Market Segment Percentages, by Application, 2021 (%)
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
Global Tafenoquine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tafenoquine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tafenoquine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tafenoquine revenues share in global market, 2021 (%)
Key companies Tafenoquine sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Tafenoquine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck